Mark W. Schwartz

2014

In 2014, Mark W. Schwartz earned a total compensation of $1M as President & Chief Executive Officer at Galena Biopharma, a 36% decrease compared to previous year.

Compensation breakdown

Bonus$288,000
Option Awards$306,180
Salary$419,105
Other$1,477
Total$1,014,762

Schwartz received $419.1K in salary, accounting for 41% of the total pay in 2014.

Schwartz also received $288K in bonus, $306.2K in option awards and $1.5K in other compensation.

Rankings

In 2014, Mark W. Schwartz's compensation ranked 7,545th out of 13,032 executives tracked by ExecPay. In other words, Schwartz earned more than 42.1% of executives.

ClassificationRankingPercentile
All
7,545
out of 13,032
42nd
Division
Manufacturing
2,789
out of 4,966
44th
Major group
Chemicals And Allied Products
945
out of 1,686
44th
Industry group
Drugs
743
out of 1,365
46th
Industry
Pharmaceutical Preparations
576
out of 1,043
45th
Source: SEC filing on June 3, 2016.

Schwartz's colleagues

We found two more compensation records of executives who worked with Mark W. Schwartz at Galena Biopharma in 2014.

2014

Margaret Kivinski

Galena Biopharma

General Counsel

2014

Ryan Dunlap

Galena Biopharma

Chief Financial Officer

You may also like